Stem cell-based implants successfully secrete insulin in patients with type 1 diabetes
December 2, 2021
Interim results from a multicenter clinical trial demonstrate insulin secretion from engrafted cells in patients with type 1 diabetes. The safety, tolerability, and efficacy of the implants, which consisted of pancreatic endoderm cells derived from human pluripotent stem cells (PSCs), were tested in 26 patients. While the insulin secreted by the implants did not have clinical effects in the patients, the data are the first reported evidence of meal-regulated insulin secretion by differentiated stem cells in human patients.
Stem Cells therapy
Human placenta stem cells help people recover from hip surgery
STEM cells taken from placentas have healing properties that can help people recover from having their hip joint replaced. Placentas are normally thrown away after childbirth, but now Israeli company Pluristem has taken discarded placentas Read more…